Nanoparticles to Cross Biological Barriers - Biomaterials Science: An Integrated Clinical and Engineering Approach - page 111

38. N. Desai, V. Trieu, Z. Yao, L. Louie, S. Ci, A. Yang, C. Tao, T. De, B. Beals,
D. Dykes, P. Noker, R. Yao, E. Labao, M. Hawkins, P. Soon-Shiong, Increased
antitumor activity, intratumor paclitaxel concentrations, and endothelial cell
transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared
with cremophor-based paclitaxel. Clinical Cancer Research 12 (2006) 1317-1324.
39. T. Kim, D. Kim, J. Chung, S.G. Shin, S. Kim, D.S. Heo, N.K. Kim, Y. Bang, Phase
I and pharmacokinetic study of genexol-pm, a cremophor-free, polymeric
micelle-formulated paclitaxel, in patients with advanced malignancies, Clinical
Cancer Research 10 (2004) 3708-3716.
40. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, S.W. Kim, M.H. Seo, In vivo
evaluation of polymeric micellar paclitaxel formulation: Toxicity and efficacy,
J. Controlled Release 72 (2001) 191-202.
41. A. Akinc, A. Zumbuehl, M. Goldberg, E.S. Leshchiner, V. Busini, N. Hossain,
S.A. Bacallado, et al. A combinatorial library of lipid-like materials for delivery
of RNAi therapeutics, Nat Biotech 26 (2008) 561-569.
42. M. John, R. Constien, A. Akinc, M. Goldberg, Y. Moon, M. Spranger, P. Hadwiger,
J. Soutschek, H. Vornlocher, M. Manoharan, M. Stoffel, R. Langer, D.G. Anderson,
J.D. Horton, V. Koteliansky, D. Bumcrot, Effective RNAi-mediated gene silenc-
ing without interruption of the endogenous microRNA pathway, Nature 449
(2007) 745-747.
43. D.G. Anderson, W. Peng, A. Akinc, N. Hossain, A. Kohn, R. Padera, R. Langer,
J.A. Sawicki, A polymer library approach to suicide gene therapy for cancer,
Proceedings of the National Academy of Sciences of the United States of America 101
(2004) 16028-16033.
44. E.A. Schellenberger, F. Reynolds, R. Weissleder, L. Josephson, Surface-
functionalized nanoparticle library yields probes for apoptotic cells,
ChemBioChem 5 (2004) 275-279.
45. J. Kim, J.E. Lee, J. Lee, Y. Jang, S. Kim, K. An, J.H. Yu, T. Hyeon, Generalized fabri-
cation of multifunctional nanoparticle assemblies on silica spheres, Angewandte
Chemie 118 (2006) 4907-4911.
46. A.G. Tkachenko, H. Xie, D. Coleman, W. Glomm, J. Ryan, M.F. Anderson,
S. Franzen, D.L. Feldheim, multifunctional gold nanoparticle peptide com-
plexes for nuclear targeting, J. Am. Chem. Soc. 125 (2003) 4700-4701.
47. L. Zhang, A.F. Radovic-Moreno, F. Alexis, F.X. Gu, P.A. Basto, V. Bagalkot, S. Jon,
R.S. Langer, O.C. Farokhzad, Co-delivery of hydrophobic and hydrophilic drugs
from nanoparticle-aptamer bioconjugates, ChemMedChem 2 (2007) 1268-1271.
48. A.Z. Wang, V. Bagalkot, C.C. Vasilliou, F. Gu, F. Alexis, L. Zhang, M. Shaikh,
K. Yuet, M.J. Cima, R. Langer, P.W. Kantoff, N.H. Bander, S. Jon, O.C. Farokhzad,
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for com-
bined prostate cancer imaging and therapy, ChemMedChem 3 (2008) 1311-1315.
49. R. Weissleder, M.J. Pittet, Imaging in the era of molecular oncology, Nature 452
(2008) 580-589.
50. S. Kumar, J. Aaron, K. Sokolov, Directional conjugation of antibodies to nanopar-
ticles for synthesis of multiplexed optical contrast agents with both delivery and
targeting moieties, Nat. Protocols 3 (2008) 314-320.
51. R.K. Jain, Normalization of tumor vasculature: An emerging concept in antian-
giogenic therapy, Science 307 (2005) 58-62.
52. A. Hormigo, P.H. Gutin, S. Rafii, Tracking normalization of brain tumor vascula-
ture by magnetic imaging and proangiogenic biomarkers, Cancer Cell 11 (2007) 6-8.